PI3K Inhibitor Fails to Pass Muster With FDA Advisory Committee

High rates of toxicity, suggestion of survival detriment sway duvelisib vote

Related Keywords

Colorado ,United States ,Boston ,Massachusetts ,Dana Farber Cancer Institute ,Jorge Garcia ,David Harrington ,Secura Bio ,Mikkael Sekeres ,Charles Bankhead ,Oncologic Drugs Advisory Committee ,University Of Miami Sylvester Comprehensive Cancer Center ,University Of Colorado Cancer Center ,Case Western Reserve University In Cleveland ,Drugs Advisory Committee ,Playing With ,Sylvester Comprehensive Cancer Center ,Christopher Lieu ,Colorado Cancer Center ,Case Western Reserve University ,Medpage Today ,